

Dr. Robert Ramirez
Medical Oncologist
1 Podcast on BackTable
Dr. Robert Ramirez is a medical oncologist practicing at Vanderbilt University Medical Center in Nashville, Tennessee.
Learn from the experiences and expertise of Dr. Robert Ramirez and other leading voices in your specialty on the BackTable app.

Episode # 74 • 28 Jul 2026
Systemic Therapy Strategies for Treating Neuroendocrine Tumors
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)? In this new episode of BackTable Tumor Board, Drs. Lingling Du, Chih-Yi Liao, and Robert Ramirez discuss the use of systemic or radioligand therapies for metastatic well-differentiated NETs.
This podcast is supported by
More from Dr. Robert Ramirez
About
Robert Ramirez, DO, is a medical oncologist specializing in the treatment of thoracic and neuroendocrine malignancies. He is Associate Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine, at Vanderbilt University Medical Center. He earned his medical degree from the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. He completed an internal medicine residency at Cooper University Hospital in Camden, New Jersey. He then completed a hematology and medical oncology fellowship at the University of Tennessee Health Sciences Center in Memphis, Tennessee and served as chief fellow.
Dr. Ramirez is a Fellow of the American College of Physicians, and a member of American Society of Clinical Oncology, the International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS). He is a member of the Communications Committee for the IASLC and serves on the Board of Directors for NANETS as well as the Scientific Review and Research Committees.
His clinical and research interests include neuroendocrine tumors (NETs) and lung cancer. He has a specific interest in NETs of the lung ranging from diffuse idiopathic pulmonary neuroendocrine tumor cell hyperplasia (DIPNECH) and carcinoid tumors to small cell lung cancer and other high-grade neuroendocrine carcinomas. He is active in clinical trial design including investigator-initiated trials. Dr. Ramirez enjoys teaching residents and fellows and has multiple publications and given many lectures for the scientific community on the topics of NETs and lung cancers.
Visit Vanderbilt Health to learn more about Dr. Robert Ramirez.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.